During the COVID-19 pandemic, rates of new stimulant prescriptions dispensed to adults accelerated rapidly, according to a study published online March 9 in CMA ...

Telemedicine visits may cost less than in-person care without increasing subsequent short-term health care use.

Desmoda (desmopressin acetate) Vasopressin 2 receptor agonist Management of central diabetes insipidus as antidiuretic replacement therapy for adults and pediatric patients. FDA Approves Desmoda Oral ...

Authors say that individuals with COVID-19, particularly those at high risk for kidney disease, may need additional monitoring of kidney function. HealthDay News — Past COVID-19 illness increases the ...

Dr Vinay Prasad, who leads the FDA division that oversees vaccines and complex medical treatments, is leaving the agency at the end of April.

The FDA accepts the NDA for lorundrostat, a selective aldosterone synthase inhibitor, for adults with uncontrolled or resistant hypertension.

Conferences are an excellent way to stay up-to-date on the latest research and to meet and connect with fellow cardiologists. These events are an opportunity to learn better ways to provide quality ...

Updated mRNA-1273 vaccine was effective against severe COVID-19 outcomes in older and high-risk adults during the 2024-2025 season.

Low income and high social deprivation are independently associated with adverse clinical outcomes in patients with HCM.

Respiratory sarcopenia, defined by low diaphragm thickness and reduced FVC, is associated with increased 2-year mortality in HF.

Taking GLP-1 RAs is associated with fewer hospitalizations overall and less need for medications used to stop and prevent ...

Twenty percent of potentially eligible youth are prescribed GLP-1 RAs, with the odds of prescription higher with increasing age and BMI.